JMIR J Med Internet Res Journal of Medical Internet Research 1438-8871 JMIR Publications Toronto, Canada v22i10e19179 33034566 10.2196/19179 Review Review Measurement Properties of Existing Patient-Reported Outcome Measures on Medication Adherence: Systematic Review Parra-Calderón Carlos Luis Kardas Przemyslaw Román-Villarán Esther Wee Sharon Kwan Yu Heng PhD 1
Program in Health Services and Systems Research, Duke-NUS Medical School 8 College Road Singapore, 169857 Singapore 65 63778465 yuheng_02071988@hotmail.com
2 https://orcid.org/0000-0001-7802-9696 Weng Si Dun BSc 2 https://orcid.org/0000-0002-9921-3908 Loh Dionne Hui Fang BEng 3 https://orcid.org/0000-0002-6781-5680 Phang Jie Kie BSc 4 https://orcid.org/0000-0003-1357-8568 Oo Livia Jia Yi BSc 2 https://orcid.org/0000-0002-5777-5435 Blalock Dan V PhD 5 6 https://orcid.org/0000-0002-8349-9825 Chew Eng Hui PhD 2 https://orcid.org/0000-0002-2615-8987 Yap Kai Zhen PhD 2 https://orcid.org/0000-0002-8440-0313 Tan Corrinne Yong Koon MBA 7 https://orcid.org/0000-0001-9538-1683 Yoon Sungwon PhD 1 3 https://orcid.org/0000-0001-9458-6097 Fong Warren FAMS 4 8 9 https://orcid.org/0000-0003-1891-1892 Østbye Truls PhD 1 https://orcid.org/0000-0002-0662-7440 Low Lian Leng FCFP(S) 3 10 11 https://orcid.org/0000-0003-4228-2862 Bosworth Hayden Barry PhD 5 6 12 13 https://orcid.org/0000-0001-6188-9825 Thumboo Julian FRCP 1 4 9 https://orcid.org/0000-0001-6712-5535 Program in Health Services and Systems Research, Duke-NUS Medical School Singapore Singapore Department of Pharmacy National University of Singapore Singapore Singapore PULSES Centre Grant SingHealth Regional Health System Singapore Singapore Department of Rheumatology and Immunology Singapore General Hospital Singapore Singapore Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT) Durham Veterans Affairs Health Care System Durham, NC United States Department of Psychiatry and Behavioral Sciences Duke University School of Medicine Durham, NC United States Pharmacy Transformation Office National Healthcare Group Pharmacy Singapore Singapore Duke-NUS Medical School Singapore Singapore NUS Yong Loo Lin School of Medicine National University of Singapore Singapore Singapore Department of Family Medicine and Continuing Care Singapore General Hospital Singapore Singapore Post Acute and Continuing Care Outram Community Hospital Singapore Singapore Department of Population Health Sciences Duke University Medical Center Durham, NC United States School of Nursing Duke University Medical Center Durham, NC United States Corresponding Author: Yu Heng Kwan yuheng_02071988@hotmail.com 10 2020 9 10 2020 22 10 e19179 11 4 2020 14 6 2020 5 7 2020 8 8 2020 ©Yu Heng Kwan, Si Dun Weng, Dionne Hui Fang Loh, Jie Kie Phang, Livia Jia Yi Oo, Dan V Blalock, Eng Hui Chew, Kai Zhen Yap, Corrinne Yong Koon Tan, Sungwon Yoon, Warren Fong, Truls Østbye, Lian Leng Low, Hayden Barry Bosworth, Julian Thumboo. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 09.10.2020. 2020

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.

 Background

Medication adherence is essential for improving the health outcomes of patients. Various patient-reported outcome measures (PROMs) have been developed to measure medication adherence in patients. However, no study has summarized the psychometric properties of these PROMs to guide selection for use in clinical practice or research.

 Objective

This study aims to evaluate the quality of the PROMs used to measure medication adherence.

 Methods

This study was guided by the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) guidelines. Relevant articles were retrieved from the EMBASE, PubMed, Cochrane Library, Web of Science, and CINAHL (Cumulative Index to Nursing and Allied Health Literature) databases. The PROMs were then evaluated based on the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) guidelines.

 Results

A total of 121 unique medication adherence PROMs from 214 studies were identified. Hypotheses testing for construct validity and internal consistency were the most frequently assessed measurement properties. PROMs with at least a moderate level of evidence for ≥5 measurement properties include the Adherence Starts with Knowledge 20, Compliance Questionnaire-Rheumatology, General Medication Adherence Scale, Hill-Bone Scale, Immunosuppressant Therapy Barrier Scale, Medication Adherence Reasons Scale (MAR-Scale) revised, 5-item Medication Adherence Rating Scale (MARS-5), 9-item MARS (MARS-9), 4-item Morisky Medication Adherence Scale (MMAS-4), 8-item MMAS (MMAS-8), Self-efficacy for Appropriate Medication Adherence Scale, Satisfaction with Iron Chelation Therapy, Test of Adherence to Inhalers, and questionnaire by Voils. The MAR-Scale revised, MMAS-4, and MMAS-8 have been administered electronically.

 Conclusions

This study identified 121 PROMs for medication adherence and provided synthesized evidence for the measurement properties of these PROMs. The findings from this study may assist clinicians and researchers in selecting suitable PROMs to assess medication adherence.

 systematic review reliability and validity medication adherence patient reported outcome measures Introduction

Medication adherence is known as “the degree to which the person’s behaviour corresponds with the agreed recommendations from a healthcare provider” [1]. Medication adherence is essential when it comes to improving the health outcomes of patients, especially for chronic diseases [2,3]. However, only approximately half of the patients worldwide adhere to their prescribed medication regimen [4]. Reasons for medication nonadherence include complexity of the treatment regimen, poor communication with health care providers, and concerns about side effects from taking medications [5]. Poor medication adherence may lead to worse health outcomes and higher rates of mortality and morbidity [1,6]. Nonadherence also incurs a high cost burden to the health care system by increasing hospital visits as well as causing unnecessary escalation to more expensive treatments [1]. Therefore, improving medication adherence is key to improving treatment outcomes [7,8].

To successfully improve medication adherence, there is a need for the accurate assessment of medication adherence. Current practices for measuring medication include direct measures such as drug assays of blood or urine as well as indirect measures of adherence such as pill count, electronic monitoring devices, and the use of big data such as review of prescription records and claims [9,10]. Some of these measures are not time efficient and are likely to be unsustainable in clinical practice. Various patient-reported outcome measures (PROMs) such as the Morisky Medication Adherence Scale (MMAS) [11], Hill-Bone Compliance Scale [12], and Medication Adherence Rating Scale (MARS) [13] have been developed to measure self-reported adherence to medications. These PROMs may be useful in clinical practice because they are easy to administer. On the basis of the patients’ PROM ratings, health care professionals may be able to provide timely feedback. Thus, underlying issues that contribute to medication noncompliance can be addressed at the point of care [14].

A number of previous studies have been conducted to validate PROMs on medication adherence [12,15-17], and a previous systematic review found 14 PROMs that assessed adherence to inhaled asthma maintenance medication alone [18]. However, to date, there is no comprehensive review that summarizes the psychometric properties of PROMs for medication adherence, which is essential to guide the selection of suitable PROMs to evaluate medication adherence in patients. Hence, we carried out a systematic review to identify studies that investigated PROMs for medication adherence and to evaluate the quality of these PROMs.

 Methods

This study was conducted with reference to the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) statement [19]. The measurement properties of each PROM were evaluated based on the COnsensus-based Standards for the selection of health Measurement Instruments(COSMIN) guidelines [20,21]. The COSMIN guidelines evaluate PROM development and the following 9 measurement properties: “content validity,” “structural validity,” “internal consistency,” “cross-cultural validity/measurement invariance,” test-retest “reliability,” “measurement error,” “criterion validity,” “hypotheses testing for construct validity,” and “responsiveness” [21,22]. Of note, the assessment of “convergent validity,” “discriminant validity,” and “known-group validity” falls under “hypotheses testing for construct validity” [23,24]. We also assumed that “concurrent validity” and “predictive validity” can be evaluated by the same measurement property, “hypothesis testing for construct validity,” and sensitivity to change can be evaluated under “responsiveness” as well [22,25,26].

Search Strategy

The EMBASE, PubMed, Cochrane Library, Web of Science, and CINAHL databases were searched for relevant studies published before November 1, 2019. A search strategy (Multimedia Appendix 1) consisting of adherence, PROMs, and measurement properties was used. Search filters created by Terwee et al [27], which consists of a combination of search terms, were also used to enhance the sensitivity of searches, where available. For the adherence construct, synonyms such as compliance were used in the search. Duplicates were removed from the final search library.

 Study Selection

Articles included in this study were full-text publications in English, validating medication adherence PROMs, with the assessment of at least one measurement property listed in the COSMIN [24,28]. We excluded animal studies, case studies, narrative reviews, expert opinions, conference abstracts, and PROMs completed by proxy [29]. In total, 2 independent reviewers (SW and LO) screened the titles and abstracts of the studies according to the inclusion and exclusion criteria. Opinions from a third reviewer (YK) were sought in the event of any disagreements. The remaining full-text articles were then evaluated by the same 2 independent reviewers for inclusion and exclusion. Additional articles for inclusion into the final pool of articles were also identified from the reference list of articles during the full-text screening phase [30].

 Extraction of Data

The following data were then extracted from the included articles by 2 independent reviewers (SW and LO), where available:

General characteristics of the study population: age, sample size, gender, and country.

Characteristics of disease or condition: disease studied, duration of illness, or treatment.

PROM characteristics: methods of administration, availability of electronic administration, language, response scale, domains, and number of items.

 Assessment of Methodological Quality

The methodological quality of the studies was assessed by 2 independent reviewers (SW and LO). Any disagreement was resolved in consultation with a third reviewer (JP). Each measurement property was assessed based on a 4-point scale: “inadequate,” “doubtful,” “adequate,” or “very good” [20,22]. The item with the worst rating under each measurement property would determine the overall rating for the specific measurement property [31].

On the basis of the COSMIN guidelines, it is recommended for the review team to determine before assessing the methodological quality of studies which outcome measurement instrument can be considered a reasonable gold standard [32]. The study team decided that there is currently no gold standard in the field of patient-reported outcomes that measure medication adherence [33,34]; thus, the assessment of criterion validity of the PROMs was not performed except when an abridged PROM was compared with the original long version, which will be regarded as the gold standard. This is in line with the consensus from the COSMIN panel that no gold standard exists for PROMs [35].

 Assessment of Psychometric Quality

The psychometric quality for each medication adherence instrument was assessed using the quality criteria by Terwee et al [36]. For each of the measurement properties evaluated in the included studies, a “positive (+),” “indeterminate (?),” or “negative (−)” rating was assigned based on the psychometric results.For example, for the internal consistency measurement property, the rating will be “+” if “at least low evidence for sufficient structural validity AND Cronbach’s alpha(s) ≥ 0.70 for each unidimensional scale or subscale.” The rating will be “−” if there is “at least low evidence for sufficient structural validity AND Cronbach’s alpha(s) < 0.70 for each unidimensional scale or subscale.” The rating will be “?” if the “criteria for at least low evidence for sufficient structural validity is not met” [36].

 Evidence Synthesis

For each PROM, an evidence synthesis across studies was conducted. First, we determined whether each measurement property for a PROM had overall “sufficient (+),” “insufficient (−),” “inconsistent (±),” or “indeterminate (?)” evidence for each measurement property of the PROM. For PROMs that were assessed in more than one study, the overall rating of the level of evidence for the PROM would be sufficient (+), indeterminate (?), or insufficient (–) if the individual studies were all consistently rated as positive (+), indeterminate (?), or negative (-), respectively. If the results of individual studies were inconsistent, the overall rating of the level of evidence for the PROM would be inconsistent.

We also graded the quality of evidence for each measurement property of PROM as “high,” “moderate,” “low,” or “very low” level of evidence based on the guidelines from the modified Grading of Recommendations Assessment, Development and Evaluation approach for systematic reviews of clinical trials [22,37].

 Results Search Results and Study Characteristics

In total, 51,426 articles were retrieved from the 5 databases. After removing 8286 duplicates and 42,836 articles during title and abstract screening, 304 articles remained for full-text review. A total of 98 articles were further eliminated during full-text article screening. An additional 8 relevant articles were identified through hand-searching of the reference lists from the included articles to obtain a final list of 214 articles (Figure 1). A total of 240 PROMs were evaluated across 214 studies, and 121 unique medication adherence PROMs in 32 languages from 48 countries were identified (Table 1).

Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram for the systematic review. CINAHL: Cumulative Index to Nursing and Allied Health Literature; PROM: patient-reported outcome measure.

Study characteristics of included articles (N=214).

Study characteristics Values, n (%)
Sample sizea
<50 17 (7.9)
50-99 31 (14.4)
100-199 62 (29.0)
200-299 32 (15.0)
300-399 23 (10.7)
400-499 15 (7.0)
>500 35 (16.4)
Mean age (years)a,b
<20 9 (4.2)
20-39 28 (13.1)
40-59 97 (45.3)
60-79 55 (25.7)
>80 2 (0.9)
Proportion of males (%) a
0-20 15 (7.0)
21-40 47 (22.0)
41-60 78 (36.4)
61-80 38 (17.8)
81-100 23 (10.7)
Mean treatment/disease durationa (years)
<1 3 (1.4)
1-5 11 (5.1)
6-10 27 (12.6)
11-15 16 (7.5)
>15 2 (0.9)

aSome values were not reported.

bSome values were reported as median, range, or not reported.

 PROM Characteristics

The characteristics of the medication adherence PROM are presented in Multimedia Appendix 2 [38-51]. The most extensively studied PROMs were the 8-item MMAS (MMAS-8)and 4-item MMAS(MMAS-4), which were studied in 27 and 18 studies, respectively. Among the 121 PROMs, 15 PROMs have been administered electronically—Adult AIDS Clinical Trials Group (AACTG) adherence items [52], Fredericksen et al [38], Item Response Theory-30 [53], LeastAbsolute Shrinkage and Selection Operator-10 [53], Medication Adherence Reasons Scale (MAR-Scale) [54], MAR-Scale (revised) [55], MARS [56], Medication Intake Survey-Asthma [57], MMAS-4 [54], MMAS-8 [58], Multiple Sclerosis Treatment Adherence Questionnaire [59], Probabilistic Medication Adherence Scale [56], Self-Rating Scale Item [52], visual analog scale [52], and WedAd-Q Questionnaire [60].

 Assessment of Methodological and Psychometric Quality

Outcomes on the assessment of methodological quality and study quality of PROMs are summarized in Multimedia Appendix 3 [13,17,38-54,56,57,59,61-248]. In terms of validity, “hypotheses testing for construct validity,”“structural validity,” and “content validity” were assessed in 181, 92, and 92 studies, respectively. In terms of reliability, “internal consistency” and “reliability” were assessed in 138 and 27 studies, respectively.

No studies assessed “measurement error” or “cross-cultural validity/measurement invariance.”Of note, 46 studies performed translation of PROMs, but none of them assessed measurement invariance or differential item functioning. Furthermore, although 75 studies assessed PROM development, only one of them obtained very good methodological quality.

 Evidence Synthesis

The results for the evidence synthesis for the PROMs are summarized in Table 2. PROMs with at least a moderate level of evidence for ≥5 measurement properties include the Adherence Starts with Knowledge 20 (ASK-20), Compliance Questionnaire-Rheumatology (CQR), General Medication Adherence Scale (GMAS), Hill-Bone Scale, Immunosuppressant Therapy Barrier Scale (ITBS), MAR-Scale revised, MARS-5, MARS-9, MMAS-4, MMAS-8, Self-efficacy for Appropriate Medication Adherence Scale (SEAMS), Satisfaction with Iron Chelation Therapy (SICT), Test of Adherence to Inhalers (TAI), and the questionnaire by Voils.

Evidence synthesis of measurement properties for each patient-reported outcome measure.

PROMa Number of studies PROM development Content validity Structural validity Internal consistency Cross-cultural validity/measurement invariance Reliability Measurement error Criterion validity Hypotheses testing for construct validity Responsiveness
Adult Asthma Adherence Questionnaire 1 0b ?c/Bd ?/B −e/Cf 0 0 0 0 −/B +g/B
Adult AIDS Clinical Trials Group 8 0 ?/Dh ?/B +/Ai 0 0 0 0 ±j/C +/C
Antidepressant Adherence Scale 1 D ?/D 0 −/D 0 0 0 0 −/C 0
Adherence Barrier Questionnaire 2 D 0 ?/B +/A 0 0 0 0 −/B 0
Adherence tool for chronic myelomonocytic leukemia 1 D 0 0 −/C 0 0 0 0 −/D −/D
Adherence Evaluation of Osteoporosis Treatment Questionnaire-12 1 0 0 0 0 0 0 0 0 +/A +/A
Antipsychotic Medication Beliefs and Attitudes Scale 1 D +/C −/B +/A 0 0 0 0 +/B 0
Adherence to Pulmonary Rehabilitation Questionnaire 1 C +/C ?/B +/D 0 0 0 0 0 0
ARMSk 1 C +/C ?/B +/A 0 ?/C 0 0 +/B 0
ARMS-7 1 0 ?/C −/A +/A 0 +/B 0 0 0 0
ASKl-12 1 0 0 ?/B +/A 0 +/B 0 0 +/A 0
ASK-20 3 B +/B ?/B +/D 0 +/B 0 0 ±/A −/B
Attitudes to mesalamine questionnaire 1 D 0 0 0 0 0 0 0 +/A +/A
Adherence self-report questionnaire 1 0 +/C 0 0 0 −/D 0 0 0 −/B
Axelsson et alm [39] 1 D 0 ?/B +/A 0 0 0 0 +/C 0
Basel Assessment of Adherence to Immunosuppressive Medications Scale 1 0 +/B ?/B +/D —n +/A 0 0 +/B 0
Brief Evaluation of Medication Influences and Beliefs 1 D ?/D ?/C −/D 0 ?/D 0 0 −/D +/C
Beliefs Related to Medication Adherence 1 D ?/D ?/D +/D 0 0 0 0 +/D 0
Brief Medication Adherence Scale 1 D 0 ?/B ?/D 0 +/B 0 0 +/C 0
Beliefs about Medication Compliance Scale 1 D +/C ?/B +/A 0 0 0 0 0 0
Brief Medication Questionnaire 4 D ?/C 0 0 0 +/B 0 0 +/B +/C
Center for Adherence Support Evaluation Adherence Index 2 0 0 0 0 0n ?/D 0 0 +/B −/B
Chronic Disease Compliance Instrument 3 A +/A ?/B +/B —n 0 0 0 −/B 0
CEAT-VIH 1 0 +/B 0 +/D 0 0 0 0 +/C 0
Chaiyachatiet alm [40] 1 0 0 0 0 0 0 0 0 0 −/C
Compliance assessment 1 0 0 0 ?/D 0 0 0 0 +/B 0
Cohort Study of Medication Adherence Among Older Adults self-report tool 1 D 0 ?/D 0 0 0 0 0 +/B +/B
CQRo 4 B +/B ?/B +/A 0n ±/B 0 0 ±/B +/A
CQR-5 1 0 +/A +/D +/A 0 0 0 0 +/B −/B
Da et alm [41] 1 0 0 0 0 0 0 0 0 −/C −/B
DAIp 1 D 0 0 +/D 0 ?/D 0 0 +/B 0
DAI-10 2 0 0 0 +/C 0 0 0 0 ±/A −/B
DAI-9 1 0 0 ?/C 0 0 −/D 0 0 −/D 0
Diagnostic Adherence to Medication Scale 1 B +/B 0 0 0 0 0 0 +/A 0
Demirtas et alm [42] 1 B +/B ?/A +/A 0 ?/C 0 0 +/C 0
Danish version of Medication Adherence Report Scale-4 1 0 ?/D 0 +/C 0 0 0 0 −/D 0
Diabetes Management Questionnaire 1 D ?/C 0 +/A 0 −/C 0 0 +/B 0
Diabetes Medication Self-efficacy Scale 2 D +/B ?/B +/D 0n +/B 0 0 +/C −/B
Environmental Barriers to Adherence Scale 1 0 0 0 +/A 0 ?/D 0 0 +/D 0
Eye-Drop Satisfaction Questionnaire 2 D +/C ?/B +/A 0 0 0 0 ?/C 0
End-Stage Renal Disease Adherence Questionnaire 2 D +/B 0 0 0n +/C 0 0 −/B 0
Every Visit Adherence Questionnaire 1 0 0 0 0 0 0 0 0 +/D 0
Five-dimension adherence model 1 D 0 0 0 0 0 0 0 0 +/A
Fredericksen et alm [249] 1 C +/A 0 0 0 +/A 0 0 0 0
General adherence tendency measure 1 D 0 0 0 0 0 0 0 −/B −/B
General Medicine Adherence Scale 3 C +/B +/A +/A 0n ±/B 0 0 +/B +/C
Godin et alm [43] 2 C ?/C 0 0 0 0 0 0 −/C +/C
GTCATq 1 D ?/B ?/D −/B 0 ?/D 0 0 +/B 0
GTCAT (reduced) 2 0 ?/B −/C −/A 0 +/B 0 0 −/B 0
Hill-Bone Scale 5 B +/A ?/B +/B 0n 0 0 0 +/A 0
Hill-Bone Scale (modified) 1 0 ?/C 0 −/D 0n 0 0 0 0 0
HIV Intention Measure 1 C +/B ?/B +/A 0 0 0 0 +/C 0
HIV Symptom Quality of Life Adherence Questionnaire 1 D 0 ?/B +/C 0 0 0 0 +/B 0
Iraqi Anti-Diabetic Medication Adherence Scale 1 C ?/C 0 +/B 0n ?/C 0 0 +/B +/C
Item Response Theory-30 1 B +/B ?/B 0 0 0 0 0 ?/C +/B
Immunosuppressant Therapy Adherence Scale 2 0 0 ?/B +/D 0n 0 0 0 ±/B 0
Immunosuppressant Therapy Barrier Scale 1 C +/B ?/B +/A 0 0 0 0 +/A +/A
Kennedy et alm [44] 1 D +/B 0 0 0 0 0 0 0 0
Kerr et alm [45] 1 D 0 0 0 0 0 0 0 −/D −/D
Least absolute shrinkage and selection operator-10 1 B +/B ?/B 0 0 0 0 0 ?/C +/B
Long-Term Medication Behaviour Self-Efficacy Scale 1 D ?/D 0 0 0 0 0 0 0 0
Modified Drug Adherence Work-up Tool 2 0 ?/D ?/D +/D 0 0 0 0 −/B +/B
Medication Adherence Questionnaire 1 D ?/D 0 +/D 0n +/D 0 0 0 0
MAR-Scaler 1 C ?/D ?/B −/A 0 −/D 0 0 +/D 0
MAR-Scale (revised) 2 B +/B ?/B +/A 0 0 0 0 +/B 0
MARSs 8 D +/D ?/B ±/A 0n ?/D 0 0 ±/B ±/B
MARS-10 1 0 ?/D ?/B +/A 0n 0 0 0 +/B +/B
MARS-5 8 0 +/B ?/B +/B 0n ±/B 0 0 ±/A ±/B
MARS-9 2 0 +/B ?/B +/A 0 −/B 0 0 ±/B 0
MASESt 2 D +/A ?/B +/A 0 −/D 0 0 ±/A 0
MASES-R 1 0 0 ?/B +/D 0 −/C 0 0 −/B 0
Medication Adherence Self-Report Inventory 6 D 0 0 +/B 0 +/D 0 0 +/A +/A
Medication adherence scale 1 D +/C −/A +/A 0 0 0 0 −/B 0
Medication adherence survey 1 B +/B 0 0 0 0 0 0 +/D 0
Medication Adherence Estimation and Differentiation Scale 1 C ?/B +/A +/A 0 0 0 0 +/D −/A
Medication Intake Survey-Asthma 1 B +/B 0 0 0 −/B 0 0 +/B 0
MMASu-4 18 0 +/C ?/B −/B 0 ±/B 0 0 ±/A −/B
MMAS-7 1 0 0 0 0 0n 0 0 0 +/B 0
MMAS-8 27 0 +/B ±/A ±/A 0n +/B 0 0 ±/A −/B
MMAS-9 1 0 0 +/A −/A 0 ?/C 0 0 −/B 0
Medication Nonpersistence Scale 1 C ?/C +/A +/D 0 0 0 0 +/C −/D
Medical Outcomes Study General Adherence Scale 1 0 0 0 +/D 0 0 0 0 −/C 0
Multiple Sclerosis Treatment Adherence Questionnaire 1 C ?/B 0 −/A 0 0 0 0 +/A 0
Outcome Expectations for Osteoporosis Medication Adherence Scale 2 D +/B ±/A +/A 0 0 0 0 −/C 0
Perceived Barriers to Antiretroviral Therapy Adherence Scale 1 B +/C ?/B ?/C 0n −/C 0 0 +/C 0
Pictographic Self-Efficacy Scale 1 D +/B 0 −/A 0 −/D 0 0 −/B 0
Patient Rating of Compliance Scale 1 0 0 0 0 0 0 0 0 +/B 0
Patient Preference Questionnaire 1 D +/D 0 +/D 0 0 0 0 0 0
Probabilistic Medication Adherence Scale 1 C ±/C −/A +/C 0 0 0 0 0 0
Number of pills taken or prescribed 2 0 0 0 ?/D 0 −/D 0 0 ±/C 0
Questionnaire for Adherence with Topical Treatments in Psoriasis 1 D +/B 0 0 0 0 0 0 ±/D 0
Question of Interest 1 0 ?/D 0 0 0 0 0 0 −/D −/D
SCIv 2 0 ?/C +/A 0 0 −/B 0 0 ±/A −/B
SCI-R 1 0 +/B ?/B +/A 0n ?/D 0 0 +/D +/D
Strathclyde Compliance Risk Assessment Tool 2 0 0 0 +/B 0 0 0 0 +/B +/B
Summary of Diabetes Self-care Activities 2 0 0 0 0 0 0 0 0 ±/C 0
Self-Efficacy for Appropriate Medication Adherence Scale 3 B +/B ?/B +/A 0 +/A 0 0 ±/A 0
Self-efficacy scale 1 D ?/B ?/B +/A 0 0 0 0 ?/D 0
Self-report measures of adherence 1 0 0 0 0 0 ?/B 0 0 +/B 0
Self-report on adherence 1 0 0 0 0 0 0 0 0 −/C +/C
Self-Efficacy for Osteoporosis Medication Adherence Scale 2 D +/B −/A +/A 0 0 0 0 +/C 0
Self-Reported Adherence Questionnaire 1 0 D 0 0 0 0 0 0 ?/D 0
Satisfaction with Iron Chelation Therapy 1 B +/B ?/B +/A 0 0 0 0 +/A 0
Sidorkiewicz et alm [46] 1 B +/B 0 0 0 0 0 0 +/C 0
Simplified Medication Adherence Questionnaire 2 D ?/C 0 +/C 0 +/A 0 0 +/B −/A
Stages of Change Model Questionnaire 2 D 0 0 0 0 0 0 0 +/C 0
Special Projects of National Significance Adherence Survey 1 0 0 0 +/D 0 0 0 0 +/C 0
Self-Rating Scale Item 4 0 0 0 0 0 0 0 0 +/C +/C
Test of Adherence to Inhalers 1 B ?/B ?/B +/D 0 +/A 0 0 −/C −/A
Tan et al [47] 1 C ?/C ?/B +/A 0 +/A 0 0 +/B 0
Treatment Adherence Survey-Patient Version 1 D 0 0 0 0 +/B 0 0 −/C 0
Therapeutic Adherence Scale for Hypertensive Patients 1 0 0 +/A +/A 0 0 0 0 +/B −/B
Topical Therapy Adherence Questionnaire 1 D +/D 0 +/D 0 0 0 0 0 0
Turcu-știolică et alm [48] 1 D +/D 0 −/D 0 0 0 0 −/D 0
Visual analog scale 4 0 0 0 0 0 −/D 0 0 +/B 0
Validated Hemophilia Regimen Treatment Adherence Scale—On-Demand 1 D +/D 0 +/B 0 +/B 0 0 ±/B 0
Validated Hemophilia Regimen Treatment Regimen Treatment Adherence Scale-Prophylaxis 1 D +/D 0 +/C 0 +/C 0 0 −/C 0
Voils et alm [49] 4 C +/B +/A +/A 0n −/A 0 0 ±/A −/B
Vreeman et alm [50] 2 C ?/C 0 0 0n 0 0 0 −/C −/C
Web-Ad-Q Questionnaire 1 C +/C 0 0 0 +/D 0 0 +/C 0
Wilson et alm [51] 3 B +/B 0 +/A 0 0 0 0 +/D −/A

aPROM: patient-reported outcome measurement.

b0: Measurement properties were not assessed by the study.

c?: intermediate.

dB: moderate.

e−: insufficient.

fC: low.

g+: sufficient.

hD: very low.

iA: high.

j±: inconsistent.

kARMS: Adherence to Refills and Medications Scale.

lASK: Adherence Starts with Knowledge questionnaire.

mPROMs without proper names are labeled based on the last name of the first author who developed the instrument.

nOnly translation was done. Cross-cultural validation was not the aim of the study.

oCQR: Compliance Questionnaire on Rheumatology.

pDAI: Drug Attitude Inventory.

qGTCAT: Glaucoma Treatment Compliance Assessment Tool.

rMAR-Scale: Medication Adherence Reasons Scale.

sMARS: Medication Adherence Rating Scale.

tMASES: Medication Adherence Self-efficacy Scale.

uMMAS: Morisky Medication Adherence Scale.

vSCI: Self-Care Inventory.

 Discussion

To the best of our knowledge, this is the first systematic review that comprehensively summarized PROMs for medication adherence based on the COSMIN guidelines [21,22]. Among the 214 included articles, we identified 121 unique PROMs for medication adherence. Our study revealed the most commonly evaluated medication adherence PROMs to be the MMAS-8, MMAS-4, AACTG, MARS, and MARS-5. However, being more commonly evaluated does not mean that these PROMs have the best psychometric properties. Moreover, based on the number of studies for each PROM in Table 2, most of the PROMs have too few studies to provide a strong evidence base for their use.

Among the 15 PROMs that have been administered electronically, 3 PROMs (MAR-Scale revised, MMAS-4, and MMAS-8) have at least a moderate level of evidence for ≥5 measurement properties. Electronic administration of PROMs to measure medication adherence may be appealing in health care settings, as it may reduce the administrative burden for data collection and data entry. In addition, as web-based interventions to improve medication adherence become increasingly commonplace [250], electronic PROMs may be incorporated into web-based platforms to assess the effectiveness of these web-based interventions.

Despite a few studies claiming the use of certain PROMs and objective measures as the gold standard for measuring medication adherence, we deliberately omitted evaluating criterion validity for these studies. As mentioned in the introduction, although objective measures such as pill count, electronic monitoring devices, and big data may measure adherence indirectly, these measures are laborious, costly, and sometimes invasive, making them unsuitable for routine clinical use. Furthermore, all these surrogate measures, including PROMs, do not predict any real biological outcomes such as a reduction in viral load, blood pressure, or glucose concentration in determining medication adherence in patients. Hence, none of these measures can be deemed as a gold standard [10].

Measurement error was not evaluated because none of the studies reported the standard error of measurement, smallest detectable change, or limits of agreements required by the COSMIN. In addition, although translations of PROMs were performed in 46 studies, none of these studies assessed measurement invariance or differential item functioning; therefore, cross-cultural validity was not evaluated for any of the PROMs in this study. Moreover, only one study examined the interpretability of PROMs in the form of minimal detectable change for the MMAS-8 [251]. Further study on measurement error, cross-cultural validity, and interpretability of medication adherence PROMs is warranted.

The strengths of this study include using COSMIN guidelines, which are well regarded as a consensus-based standard for evaluating the measurement properties of PROMs [23]. The COSMIN Risk of Bias checklist employed in this study is an improvement from the original COSMIN checklist with several improvements in the standards for evaluation [21,22]. We also used sensitive search filters to retrieve and include as many potentially relevant articles as possible.

One limitation related to this study was that the selection of articles and evaluation of psychometric properties were subjective in nature and may have been prone to judgment bias. Nevertheless, the requirement by COSMIN to have 2 independent reviewers and the need for a third reviewer to reach a consensus in the case of any discrepancy occurring has helped reduce the risk of judgment bias [22,252].

Conclusions

In summary, 121 unique medication adherence PROMs were identified in 214 studies. On the basis of the COSMIN guidelines, PROMs with at least a moderate level of evidence for ≥5 measurement properties include the ASK-20, CQR, GMAS, Hill-Bone Scale, ITBS, MAR-Scale revised, MARS-5, MARS-9, MMAS-4, MMAS-8, SEAMS, SICT, TAI, and questionnaire by Voils. Of these, only the GMAS has sufficient (+) ratings for at least four measurement properties. We believe this study would assist clinicians and researchers in selecting suitable PROMs to measure medication adherence among patients. Future research may consider validating measurement errors and cross-cultural validity to further improve the insights on the measurement properties of these PROMs.

Search strategy.

Characteristics of patient reported outcome measures.

Assessment of psychometric properties of patient-reported outcome measures.

 Abbreviations AACTG

Adult AIDS Clinical Trials Group

 ASK-20

Adherence Starts with Knowledge 20

 COSMIN

Consensus-based Standards for the selection of health Measurement INstruments

 CQR

Compliance Questionnaire-Rheumatology

 GMAS

General Medication Adherence Scale

 ITBS

Immunosuppressant Therapy Barrier Scale

 MAR-Scale

Medication Adherence Reasons Scale

 MARS

Medication Adherence Rating Scale

 MARS-5

five-item Medication Adherence Rating Scale

 MARS-9

nine-item Medication Adherence Rating Scale

 MMAS-4

four-item Morisky Medication Adherence Scale

 MMAS-8

eight-item Morisky Medication Adherence Scale

 PROM

patient-reported outcome measure

 PULSES

Population-based, Unified, Learning System for Enhances and Sustainable Health

 SEAMS

self-efficacy for appropriate medication adherence scale

 SICT

satisfaction with iron chelation therapy

 TAI

Test of Adherence to Inhalers

The authors would like to thank Librarian Ms Wong Suei Nee at the National University of Singapore Medical Library for her advice on search strategies. This research was supported by the SingHealth Regional Health System Population-based, Unified, Learning System for Enhanced and Sustainable Health (PULSES) Centre Grant—Measuring Medication Adherence in Singapore (CGDec19S03), and PULSES Fellowship (CGDec19F02).

Kwan Yu Heng, Weng Si Dun, and Dionne Hui Fang Loh contributed equally as co-first authors. Truls Østbye, Low Lian Leng, Hayden Barry Bosworth, and Julian Thumboo contributed equally as senior coauthors.

None declared.

 Dal-Fabbro AL Adherence to long term therapies: evidence for action Cad. Saúde Pública 2005 08 21 4 1297 8 10.1590/s0102-311x2005000400037 Asche C LaFleur J Conner C A review of diabetes treatment adherence and the association with clinical and economic outcomes Clin Ther 2011 01 33 1 74 109 10.1016/j.clinthera.2011.01.019 21397776 S0149-2918(11)00066-X Han E Suh D Lee S Jang S The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study Res Social Adm Pharm 2014 10 6 e87 98 10.1016/j.sapharm.2014.02.001 25088545 S1551-7411(14)00025-4 Sabaté E editor. , ed. Adherence to Long-Term Therapiesvidence for Action 2003 Geneva, Switzerland World Health Organization E Lee S Raamkumar AS Li J Cao Y Witedwittayanusat K Chen L Theng Y Reasons for primary medication nonadherence: a systematic review and metric analysis J Manag Care Spec Pharm 2018 08 24 8 778 94 10.18553/jmcp.2018.24.8.778 30058985 Ho PM Rumsfeld JS Masoudi FA McClure DL Plomondon ME Steiner JF Magid DJ Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus Arch Intern Med 2006 09 25 166 17 1836 41 10.1001/archinte.166.17.1836 17000939 166/17/1836 Haynes RB Ackloo E Sahota N McDonald HP Yao X Interventions for enhancing medication adherence Cochrane Database Syst Rev 2008 04 16 2 CD000011 10.1002/14651858.CD000011.pub3 18425859 Brown M Bussell J Medication adherence: WHO cares? Mayo Clin Proc 2011 04 86 4 304 14 10.4065/mcp.2010.0575 21389250 S0025-6196(11)60007-4 PMC3068890 Zhang JX Meltzer DO Identifying patients with cost-related medication non-adherence: a big-data approach J Med Econ 2016 08 19 8 806 11 10.1080/13696998.2016.1176031 27052465 PMC5538308 Lam WY Fresco P Medication adherence measures: an overview Biomed Res Int 2015 2015 217047 10.1155/2015/217047 26539470 PMC4619779 Moon SJ Lee W Hwang JS Hong YP Morisky DE Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky medication adherence scale-8 PLoS One 2017 12 11 e0187139 10.1371/journal.pone.0187139 29095870 PONE-D-17-06120 PMC5667769 Kim M Hill M Bone L Levine D Development and testing of the hill-bone compliance to high blood pressure therapy scale Prog Cardiovasc Nurs 2000 15 3 90 6 10.1111/j.1751-7117.2000.tb00211.x 10951950 Thompson K Kulkarni J Sergejew A Reliability and validity of a new medication adherence rating scale (MARS) for the psychoses Schizophr Res 2000 05 5 42 3 241 7 10.1016/s0920-9964(99)00130-9 10785582 S0920-9964(99)00130-9 Voils CI Hoyle RH Thorpe CT Maciejewski ML Yancy WS Improving the measurement of self-reported medication nonadherence J Clin Epidemiol 2011 03 64 3 250 4 10.1016/j.jclinepi.2010.07.014 21194887 S0895-4356(10)00311-2 PMC3634915 Voils CI Maciejewski ML Hoyle RH Reeve BB Gallagher P Bryson CL Yancy WS Initial validation of a self-report measure of the extent of and reasons for medication nonadherence Med Care 2012 12 50 12 1013 9 10.1097/MLR.0b013e318269e121 22922431 PMC3494794 Korb-Savoldelli V Gillaizeau F Pouchot J Lenain E Postel-Vinay N Plouin PF Durieux P Sabatier B Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults J Clin Hypertens (Greenwich) 2012 07 14 7 429 34 10.1111/j.1751-7176.2012.00634.x 22747615 Fialko L Garety PA Kuipers E Dunn G Bebbington PE Fowler D Freeman D A large-scale validation study of the medication adherence rating scale (MARS) Schizophr Res 2008 03 100 1-3 53 9 10.1016/j.schres.2007.10.029 18083007 S0920-9964(07)00500-2 Gagné M Boulet L Pérez N Moisan J Patient-reported outcome instruments that evaluate adherence behaviours in adults with asthma: a systematic review of measurement properties Br J Clin Pharmacol 2018 09 84 9 1928 40 10.1111/bcp.13623 29710423 PMC6089817 Moher D Liberati A Tetzlaff J Altman DG PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 2009 07 21 6 7 e1000097 10.1371/journal.pmed.1000097 19621072 PMC2707599 Mokkink LB Terwee CB Patrick DL Alonso J Stratford PW Knol DL Bouter LM de Vet HC The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study Qual Life Res 2010 05 19 4 539 49 10.1007/s11136-010-9606-8 20169472 PMC2852520 Mokkink LB de Vet HC Prinsen CA Patrick DL Alonso J Bouter LM Terwee CB COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures Qual Life Res 2018 05 27 5 1171 9 10.1007/s11136-017-1765-4 29260445 10.1007/s11136-017-1765-4 PMC5891552 Prinsen CAC Mokkink LB Bouter LM Alonso J Patrick DL de Vet HC Terwee CB COSMIN guideline for systematic reviews of patient-reported outcome measures Qual Life Res 2018 05 27 5 1147 57 10.1007/s11136-018-1798-3 29435801 10.1007/s11136-018-1798-3 PMC5891568 Mokkink LB Prinsen CA Bouter LM Vet HC Terwee CB The consensus-based standards for the selection of health measurement instruments (COSMIN) and how to select an outcome measurement instrument Braz J Phys Ther 2016 01 19 20 2 105 13 10.1590/bjpt-rbf.2014.0143 26786084 S1413-35552016005000143 PMC4900032 Mokkink LB Terwee CB Patrick DL Alonso J Stratford PW Knol DL Bouter LM de Vet HC The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes J Clin Epidemiol 2010 07 63 7 737 45 10.1016/j.jclinepi.2010.02.006 20494804 S0895-4356(10)00090-9 Davidson M Keating J Patient-reported outcome measures (PROMs): how should I interpret reports of measurement properties? A practical guide for clinicians and researchers who are not biostatisticians Br J Sports Med 2014 05 48 9 792 6 10.1136/bjsports-2012-091704 23258849 bjsports-2012-091704 Husted JA Cook RJ Farewell VT Gladman DD Methods for assessing responsiveness: a critical review and recommendations J Clin Epidemiol 2000 05 53 5 459 68 10.1016/s0895-4356(99)00206-1 10812317 S0895-4356(99)00206-1 Terwee CB Jansma EP Riphagen II de Vet HC Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments Qual Life Res 2009 10 18 8 1115 23 10.1007/s11136-009-9528-5 19711195 PMC2744791 Terwee CB Prinsen CA Ricci Garotti MG Suman A de Vet HC Mokkink LB The quality of systematic reviews of health-related outcome measurement instruments Qual Life Res 2016 04 25 4 767 79 10.1007/s11136-015-1122-4 26346986 10.1007/s11136-015-1122-4 PMC4830864 Scherer RW Saldanha IJ How should systematic reviewers handle conference abstracts? A view from the trenches Syst Rev 2019 11 7 8 1 264 10.1186/s13643-019-1188-0 31699124 10.1186/s13643-019-1188-0 PMC6836535 Richards D Handsearching still a valuable element of the systematic review Evid Based Dent 2008 9 3 85 10.1038/sj.ebd.6400602 18927572 6400602 Terwee CB Mokkink LB Knol DL Ostelo RW Bouter LM de Vet HC Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist Qual Life Res 2012 05 21 4 651 7 10.1007/s11136-011-9960-1 21732199 PMC3323819 Mokkink L Prinsen C Patrick D COSMIN methodology for systematic reviews of patient-reported outcome measures (PROMs) User manual 2018 78 1 Vitolins MZ Rand CS Rapp SR Ribisl PM Sevick MA Measuring adherence to behavioral and medical interventions Control Clin Trials 2000 10 21 5 Suppl 188S 94S 10.1016/s0197-2456(00)00077-5 11018574 S0197245600000775 Smith H Hankins M Hodson A George C Measuring the adherence to medication of elderly patients with heart failure: is there a gold standard? Int J Cardiol 2010 11 5 145 1 122 3 10.1016/j.ijcard.2009.06.031 19615767 S0167-5273(09)00695-0 Mokkink LB Terwee CB Knol DL Stratford PW Alonso J Patrick DL Bouter LM de Vet HC The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content BMC Med Res Methodol 2010 03 18 10 22 10.1186/1471-2288-10-22 20298572 1471-2288-10-22 PMC2848183 Terwee CB Bot SD de BM van DW Knol DL Dekker J Bouter LM de VH Quality criteria were proposed for measurement properties of health status questionnaires J Clin Epidemiol 2007 01 60 1 34 42 10.1016/j.jclinepi.2006.03.012 17161752 S0895-4356(06)00174-0 Dijkers M - Introducing GRADE: a systematic approach to rating evidence in systematic reviews and to guideline development 2020 a Fredericksen R Yang F Gibbons L Edwards T Brown S Fitzsimmons E Alperovitz-Bichell K Godfrey M Wang A Church A Gutierrez C Paez E Dant L Loo S Walcott M Mugavero M Mayer K Mathews W Patrick D Crane P Crane H Development and content validation of measures assessing adherence barriers and behaviors for use in clinical care Res Social Adm Pharm 2019 09 15 9 1168 76 10.1016/j.sapharm.2018.10.001 30327183 S1551-7411(18)30275-4 Axelsson M Ekerljung L Lundbäck B Lötvall J Personality and unachieved treatment goals related to poor adherence to asthma medication in a newly developed adherence questionnaire - a population-based study Multidiscip Respir Med 2016 11 42 10.1186/s40248-016-0078-8 27980735 78 PMC5137217 Chaiyachati K Hirschhorn LR Tanser F Newell M Bärnighausen Till Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa AIDS Patient Care STDS 2011 03 25 3 163 70 10.1089/apc.2010.0257 21269131 PMC3048836 Da W Li X Qiao S Zhou Y Shen Z Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China PLoS One 2018 13 8 e0203032 10.1371/journal.pone.0203032 30161177 PONE-D-18-05262 PMC6116984 Demirtaş A Akbayrak N Development of an assessment scale for treatment compliance in type 2 Diabetes Mellitus in Turkish population: Psychometric evaluation International Journal of Nursing Sciences 2017 07 4 3 244 251 10.1016/j.ijnss.2017.06.002 Godin G Gagné C Naccache H Validation of a self-reported questionnaire assessing adherence to antiretroviral medication AIDS Patient Care STDS 2003 07 17 7 325 32 10.1089/108729103322231268 12952734 Kennedy SB Developing a self-administered tool to predict adherence to antiretroviral therapy: design, method, and objectives AIDS Patient Care STDS 2000 06 14 6 309 16 10.1089/10872910050046331 10897503 Kerr T Hogg RS Yip B Tyndall MW Montaner J Wood E Validity of self-reported adherence among injection drug users J Int Assoc Physicians AIDS Care (Chic) 2008 7 4 157 9 10.1177/1545109708320686 18626123 1545109708320686 Sidorkiewicz S Tran V Cousyn C Perrodeau E Ravaud P Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient BMJ Open 2016 05 10 6 5 e010510 10.1136/bmjopen-2015-010510 27165645 bmjopen-2015-010510 PMC4874131 Tan J Luo L Zhang M Chen H Zhang D Dong C Xia B Fu L Tang F Liu X Tan Q Wu Y A Chinese and Western medication adherence scale in patients with chronic kidney disease Patient Prefer Adherence 2019 13 1487 95 10.2147/PPA.S207693 31507316 207693 PMC6720156 Turcu-Stiolică A Developing of a new tool for evaluation of therapeutic adherence in COPD Farmacia 2018 10 13 66 5 920 4 10.31925/farmacia.2018.5.25 Cornelius T Voils CI Umland RC Kronish IM Validity of the self-reported domains of subjective extent of nonadherence (DOSE-nonadherence) scale in comparison with electronically monitored adherence to cardiovascular medications Patient Prefer Adherence 2019 13 1677 84 10.2147/PPA.S225460 31631982 225460 PMC6781608 Vreeman RC Nyandiko WM Ayaya SO Walumbe EG Inui TS Cognitive interviewing for cross-cultural adaptation of pediatric antiretroviral therapy adherence measurement items Int J Behav Med 2014 02 21 1 186 96 10.1007/s12529-012-9283-9 23188670 Wilson IB Fowler FJ Cosenza CA Michaud J Bentkover J Rana A Kogelman L Rogers WH Cognitive and field testing of a new set of medication adherence self-report items for HIV care AIDS Behav 2014 12 18 12 2349 58 10.1007/s10461-013-0610-1 24077970 PMC4000749 Feldman BJ Fredericksen RJ Crane PK Safren SA Mugavero MJ Willig JH Simoni JM Wilson IB Saag MS Kitahata MM Crane HM Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV AIDS Behav 2013 01 17 1 307 18 10.1007/s10461-012-0326-7 23108721 PMC3549002 Wohl DA Panter AT Kirby C Magnus BE Hudgens MG Allmon AG Mollan KR Estimating HIV medication adherence and persistence: two instruments for clinical and research use AIDS Behav 2018 03 22 3 948 60 10.1007/s10461-017-1772-z 28447269 10.1007/s10461-017-1772-z Unni EJ Farris KB Development of a new scale to measure self-reported medication nonadherence Res Social Adm Pharm 2015 11 3 e133 43 10.1016/j.sapharm.2009.06.005 21272524 S1551-7411(09)00076-X Unni E Sternbach N Goren A Using the medication adherence reasons scale (MAR-Scale) to identify the reasons for non-adherence across multiple disease conditions Patient Prefer Adherence 2019 13 993 1004 10.2147/PPA.S205359 31308635 205359 PMC6612984 Kleppe M Lacroix J Ham J Midden C The development of the ProMAS: a probabilistic medication adherence scale Patient Prefer Adherence 2015 9 355 67 10.2147/PPA.S76749 25784791 ppa-9-355 PMC4356448 Dima AL van Ganse E Laforest L Texier N de Bruin M The Astro-Lab Group Measuring medication adherence in asthma: development of a novel self-report tool Psychol Health 2017 10 32 10 1288 307 10.1080/08870446.2017.1290248 28276742 Tran V Harrington M Montori VM Barnes C Wicks P Ravaud P Adaptation and validation of the treatment burden questionnaire (TBQ) in English using an internet platform BMC Med 2014 07 2 12 109 10.1186/1741-7015-12-109 24989988 1741-7015-12-109 PMC4098922 Wicks P Massagli M Kulkarni A Dastani H Use of an online community to develop patient-reported outcome instruments: the multiple sclerosis treatment adherence questionnaire (MS-TAQ) J Med Internet Res 2011 01 24 13 1 e12 10.2196/jmir.1687 21266318 v13i1e12 PMC3221333 Vale FC Santa-Helena ET Santos MA Carvalho WM Menezes PR Basso CR Silva MH Alves AM Nemes MI Development and validation of the WebAd-questionnaire to monitor adherence to HIV therapy Rev Saude Publica 2018 52 62 10.11606/s1518-8787.2018052000337 29846437 S0034-89102018000100255 PMC5963908 Schatz M Zeiger RS Yang S Weinstein AG Chen W Saris-Baglama RN Turner-Bowker DM Development and preliminary validation of the adult asthma adherence questionnaire J Allergy Clin Immunol Pract 2013 1 3 280 8 10.1016/j.jaip.2013.03.001 24565486 S2213-2198(13)00135-9 Buscher A Hartman C Kallen MA Giordano TP Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-naïve, HIV patients HIV Clin Trials 2011 12 5 244 54 10.1310/hct1205-244 22180522 H1285272085506V4 PMC3642976 Gonzalez JS Schneider HE Wexler DJ Psaros C Delahanty LM Cagliero E Safren SA Validity of medication adherence self-reports in adults with type 2 diabetes Diabetes Care 2013 04 36 4 831 7 10.2337/dc12-0410 23204245 dc12-0410 PMC3609536 Kalichman SC Amaral CM Swetzes C Jones M Macy R Kalichman MO Cherry C A simple single-item rating scale to measure medication adherence: further evidence for convergent validity J Int Assoc Physicians AIDS Care (Chic) 2009 8 6 367 74 10.1177/1545109709352884 19952289 8/6/367 PMC3015098 Reynolds NR Sun J Nagaraja HN Gifford AL Wu AW Chesney MA Optimizing measurement of self-reported adherence with the ACTG adherence questionnaire: a cross-protocol analysis J Acquir Immune Defic Syndr 2007 12 1 46 4 402 9 10.1097/qai.0b013e318158a44f 18077832 Simoni JM Huh D Wang Y Wilson IB Reynolds NR Remien RH Goggin K Gross R Rosen MI Schneiderman N Arnsten J Golin CE Erlen JA Bangsberg DR Liu H The validity of self-reported medication adherence as an outcome in clinical trials of adherence-promotion interventions: findings from the MACH14 study AIDS Behav 2014 12 18 12 2285 90 10.1007/s10461-014-0905-x 25280447 PMC4495040 Smith SR Wahed AS Kelley SS Conjeevaram HS Robuck PR Fried MW Virahep-C Study Group Assessing the validity of self-reported medication adherence in hepatitis C treatment Ann Pharmacother 2007 07 41 7 1116 23 10.1345/aph.1K024 17519299 aph.1K024 van den Boogaard J Lyimo R Boeree M Kibiki G Aarnoutse R Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study Bull World Health Organ 2011 09 1 89 9 632 9 10.2471/BLT.11.086462 21897483 S0042-96862011000900009 PMC3165976 Chesney MA Ickovics JR Chambers DB Gifford AL Neidig J Zwickl B Wu AW Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient care committee & adherence working group of the outcomes committee of the adult AIDS clinical trials group (AACTG) AIDS Care 2000 06 12 3 255 66 10.1080/09540120050042891 10928201 Gabriel A Violato C Knowledge of and attitudes towards depression and adherence to treatment: the antidepressant adherence scale (AAS) J Affect Disord 2010 11 126 3 388 94 10.1016/j.jad.2010.07.013 20708273 S0165-0327(10)00494-5 Müller S Kohlmann T Wilke T Validation of the adherence barriers questionnaire - an instrument for identifying potential risk factors associated with medication-related non-adherence BMC Health Serv Res 2015 04 10 15 153 10.1186/s12913-015-0809-0 25884193 10.1186/s12913-015-0809-0 PMC4422301 Mueller S Wilke T Gorasso V Erhart M Kittner JM Adaption and validation of the adherence barriers questionnaire for HIV patients on antiretroviral therapy (ABQ-HIV) BMC Infect Dis 2018 11 28 18 1 599 10.1186/s12879-018-3530-x 30486795 10.1186/s12879-018-3530-x PMC6264035 Daouphars M Ouvry M Lenain P Rouvet J Jardin F Bubenheim M Varin R Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemia Pharmacotherapy 2013 02 33 2 152 6 10.1002/phar.1174 23359430 Breuil V Cortet B Cotté FE Arnould B Dias-Barbosa C Gaudin A Regnault A Roborel de Climens A Legrand E Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women Osteoporos Int 2012 02 23 2 445 55 10.1007/s00198-011-1555-8 21625889 PMC3261394 Martins MJ Pinto AM Castilho P Macedo AF Pereira AT Bajouco M Leite R Matos O Morais S Madeira N Nogueira V Roque C Santos P Santos T Santos T Santos V Troia AF Barreto-Carvalho C Assessing beliefs and attitudes towards antipsychotic medication from a recovery-based perspective: psychometric properties of a new scale Psychiatry Res 2019 03 273 325 30 10.1016/j.psychres.2019.01.043 30677722 S0165-1781(18)31557-9 Ayiesah R Leonard J Chong C Development and validation of non-adherence to pulmonary rehabilitation questionnaire: a clinical tool for patients with chronic obstructive pulmonary diseases Clin Ter 2014 165 3 123 8 10.7417/CT.2014.1708 24999563 Kripalani S Risser J Gatti ME Jacobson TA Development and evaluation of the adherence to refills and medications scale (ARMS) among low-literacy patients with chronic disease Value Health 2009 12 1 118 23 10.1111/j.1524-4733.2008.00400.x 19911444 S1098-3015(10)60682-1 Gökdoğan F Kes D Validity and reliability of the Turkish adherence to refills and medications scale Int J Nurs Pract 2017 10 23 5 10.1111/ijn.12566 28726281 Matza LS Park J Coyne KS Skinner EP Malley KG Wolever RQ Derivation and validation of the ASK-12 adherence barrier survey Ann Pharmacother 2009 10 43 10 1621 30 10.1345/aph.1M174 19776298 aph.1M174 Atsuta R To Y Sakamoto S Mukai I Kobayashi A Kinoshita A Takahashi K Assessing usability of the 'adherence starts with knowledge 20' (ASK-20) questionnaire for Japanese adults with bronchial asthma receiving inhaled corticosteroids long term Allergol Int 2017 07 66 3 411 7 10.1016/j.alit.2016.09.001 27712949 S1323-8930(16)30150-2 Hahn SR Park J Skinner EP Yu-Isenberg KS Weaver MB Crawford B Flowers PW Development of the ASK-20 adherence barrier survey Curr Med Res Opin 2008 07 24 7 2127 38 10.1185/03007990802174769 18554431 4360 Matza LS Yu-Isenberg KS Coyne KS Park J Wakefield J Skinner EP Wolever RQ Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population Curr Med Res Opin 2008 11 24 11 3197 206 10.1185/03007990802463642 18922213 4679d Zeller A Schroeder K Peters TJ An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment J Clin Epidemiol 2008 03 61 3 282 8 10.1016/j.jclinepi.2007.04.007 18226752 S0895-4356(07)00149-7 Moss AC Lillis Y Edwards George JB Choudhry NK Berg AH Cheifetz AS Horowitz G Leffler DA Attitudes to mesalamine questionnaire: a novel tool to predict mesalamine nonadherence in patients with IBD Am J Gastroenterol 2014 12 109 12 1850 5 10.1038/ajg.2014.158 24913040 ajg2014158 Marsicano ED Fernandes ND Colugnati F Grincenkov FR Fernandes NM De Geest S Sanders-Pinheiro H Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants BMC Nephrol 2013 05 21 14 108 10.1186/1471-2369-14-108 23692889 1471-2369-14-108 PMC3665586 Dolder CR Lacro JP Warren KA Golshan S Perkins DO Jeste DV Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence J Clin Psychopharmacol 2004 08 24 4 404 9 10.1097/01.jcp.0000130554.63254.3a 15232332 00004714-200408000-00008 McDonald-Miszczak L Maris P Fitzgibbon T Ritchie G A pilot study examining older adults' beliefs related to medication adherence: the BERMA survey J Aging Health 2004 11 16 5 591 614 10.1177/0898264304265772 15448274 16/5/591 Chui E Wong K Chan K Wong M Validation study of the brief medication adherence scale (BMAS) in patients with schizophrenia and related disorders in Hong Kong Asian J Psychiatr 2018 10 37 154 60 10.1016/j.ajp.2018.09.005 30265964 S1876-2018(18)30322-8 Bennett SJ Milgrom LB Champion V Huster GA Beliefs about medication and dietary compliance in people with heart failure: an instrument development study Heart Lung 1997 26 4 273 9 10.1016/s0147-9563(97)90084-4 9257137 S0147-9563(97)90084-4 Sriwarakorn S Krittiyanunt S Sakulbumrungsil R SENSITIVITY AND SPECIFICITY OF THAI-VERSION BRIEF MEDICATION QUESTIONNAIRE Journal of Health Research. Jul-Sep 2010 24 3 129 134 Svarstad BL Chewning BA Sleath BL Claesson C The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence Patient Educ Couns 1999 06 37 2 113 24 10.1016/s0738-3991(98)00107-4 14528539 S0738-3991(98)00107-4 Choo PW Rand CS Inui TS Lee MT Cain E Cordeiro-Breault M Canning C Platt R Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy Med Care 1999 09 37 9 846 57 10.1097/00005650-199909000-00002 10493464 Kerr SJ Avihingsanon A Putcharoen O Chetchotisakd P Layton M Ubolyam S Ruxrungtham K Cooper DA Phanuphak P Duncombe C Assessing adherence in Thai patients taking combination antiretroviral therapy Int J STD AIDS 2012 03 23 3 160 5 10.1258/ijsa.2009.009152 22581867 23/3/160 Mannheimer SB Mukherjee R Hirschhorn LR Dougherty J Celano SA Ciccarone D Graham KK Mantell JE Mundy LM Eldred L Botsko M Finkelstein R The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy AIDS Care 2006 10 18 7 853 61 10.1080/09540120500465160 16971298 R125525116V71224 PMC2567829 Kyngäs HA Skaar-Chandler CA Duffy ME The development of an instrument to measure the compliance of adolescents with a chronic disease J Adv Nurs 2000 12 32 6 1499 506 10.1046/j.1365-2648.2000.01611.x 11136419 jan1611 Wales S Crisp J Fernandes R Kyngas H Modification and testing of the chronic disease compliance instrument to measure treatment compliance in adolescents with asthma Contemp Nurse 2011 10 39 2 147 56 10.5172/conu.2011.147 22551427 Fernandes R Wales S Crisp J Kyngas H Modification and testing of the chronic disease compliance instrument to measure treatment compliance in adolescents with diabetes J Clin Nurs 2011 05 20 9-10 1273 81 10.1111/j.1365-2702.2010.03566.x 21492273 Dima AL Schweitzer A Diaconiţ R Remor E Wanless RS Adherence to ARV medication in Romanian young adults: self-reported behaviour and psychological barriers Psychol Health Med 2013 18 3 343 54 10.1080/13548506.2012.722648 22985131 Kampman O Lehtinen K Lassila V The reliability of compliance assessments performed by doctors and patients during neuroleptic treatment: a comparison of compliance ratings Acta Psychiatr Scand Oct 2001 104 4 - 10.1111/j.1600-0447.2001.00159.x Krousel-Wood M Joyce C Holt EW Levitan EB Dornelles A Webber LS Muntner P Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension Pharmacotherapy 2013 08 33 8 798 811 10.1002/phar.1275 23649849 PMC3729884 de Klerk E van der Heijde D van der Tempel H van der Linden S Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy J Rheumatol 1999 12 26 12 2635 41 10606375 Salt E Hall L Peden AR Home R Psychometric properties of three medication adherence scales in patients with rheumatoid arthritis J Nurs Meas 2012 20 1 59 72 10.1891/1061-3749.20.1.59 22679710 Lee JY Lee SY Hahn HJ Son IJ Hahn SG Lee EB Cultural adaptation of a compliance questionnaire for patients with rheumatoid arthritis to a Korean version Korean J Intern Med 2011 03 26 1 28 33 10.3904/kjim.2011.26.1.28 21437159 PMC3056252 Cinar F Cinar M Yilmaz S Acikel C Erdem H Pay S Simsek I AB0658 Cross-cultural adaptation, reliability, and validity of the turkish version of the compliance questionnaire on rheumatology (CQR-T) in patients with Behçet's disease Ann Rheum Dis 2015 06 9 74 Suppl 2 1118.3 9 10.1136/annrheumdis-2015-eular.3171 Hughes LD Done J Young A A 5 item version of the compliance questionnaire for rheumatology (CQR5) successfully identifies low adherence to DMARDs BMC Musculoskelet Disord 2013 10 8 14 286 10.1186/1471-2474-14-286 24103582 1471-2474-14-286 PMC3852995 Hogan TP Awad AG Eastwood R A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity Psychol Med 1983 02 13 1 177 83 10.1017/s0033291700050182 6133297 Friemann K Wciórka J [Four measures of treatment compliance among patients recovering from psychotic episodes--a comparative study] Psychiatr Pol 2013 47 5 759 73 10.12740/pp/18341 25011225 Kikkert MJ Koeter MW Dekker JJ Burti L Robson D Puschner B Schene AH The predictive validity of subjective adherence measures in patients with schizophrenia Int J Methods Psychiatr Res 2011 06 20 2 73 81 10.1002/mpr.335 21557378 PMC6878246 Stjernswärd S Persson K Nielsen R Tuninger E Levander S A modified drug attitude inventory used in long-term patients in sheltered housing Eur Neuropsychopharmacol 2013 10 23 10 1296 9 10.1016/j.euroneuro.2012.11.011 23265955 S0924-977X(12)00323-9 Garfield S Eliasson L Clifford S Willson A Barber N Developing the diagnostic adherence to medication scale (the DAMS) for use in clinical practice BMC Health Serv Res 2012 10 8 12 350 10.1186/1472-6963-12-350 23039138 1472-6963-12-350 PMC3507707 Jacobsen R Møldrup C Christrup L Sjøgren P Hansen O The Danish version of the medication adherence report scale: preliminary validation in cancer pain patients Pain Pract 2009 9 1 1 7 10.1111/j.1533-2500.2008.00245.x 19019056 PPR245 Mehta SN Nansel TR Volkening LK Butler DA Haynie DL Laffel LM Validation of a contemporary adherence measure for children with type 1 diabetes: the diabetes management questionnaire Diabet Med 2015 09 32 9 1232 8 10.1111/dme.12682 26280463 PMC4802856 Sleath B Carpenter D Blalock S Davis S Hickson R Lee C Ferreri S Scott J Rodebaugh L Cummings D Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence Patient Prefer Adherence 2016 10 1003 10 10.2147/PPA.S101349 27354769 ppa-10-1003 PMC4908948 Zheng J Wang Y Ye X Xiao L Ye J Li X Zhong M Validation of diabetes medication self-efficacy scale in Chinese with type 2 diabetes Patient Prefer Adherence 2018 12 2517 25 10.2147/PPA.S170144 30568430 ppa-12-2517 PMC6267354 Irvine AA Saunders JT Blank MB Carter WR Validation of scale measuring environmental barriers to diabetes-regimen adherence Diabetes Care 1990 07 13 7 705 11 10.2337/diacare.13.7.705 2387191 Regnault A Viala-Danten M Gilet H Berdeaux G Scoring and psychometric properties of the eye-drop satisfaction questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment BMC Ophthalmol 2010 02 1 10 1 10.1186/1471-2415-10-1 20122146 1471-2415-10-1 PMC2832632 Nordmann J Denis P Vigneux M Trudeau E Guillemin I Berdeaux G Development of the conceptual framework for the eye-drop satisfaction questionnaire (EDSQ) in glaucoma using a qualitative study BMC Health Serv Res 2007 08 6 7 124 10.1186/1472-6963-7-124 17683594 1472-6963-7-124 PMC1973077 Kim Y Evangelista LS Phillips LR Pavlish C Kopple JD The end-stage renal disease adherence questionnaire (ESRD-AQ): testing the psychometric properties in patients receiving in-center hemodialysis Nephrol Nurs J 2010 37 4 377 93 20830945 PMC3077091 Poveda V Amado L Filgueiras M Teixeira L Miranda V Santos-Silva A Paúl C Costa E End-stage renal disease adherence questionnaire: translation and validation to the Portuguese language Ren Fail 2016 11 38 10 1633 8 10.1080/0886022X.2016.1209063 27764984 Fairley C Permana A Read T Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting HIV Med 2005 09 6 5 366 9 10.1111/j.1468-1293.2005.00322.x 16156886 HIV322 Kandrotaite K Smigelskas K Janusauskiene D Jievaltas M Maciulaitis R Briedis V Development of a short questionnaire to identify the risk of nonadherence to antibiotic treatment Curr Med Res Opin 2013 11 29 11 1555 63 10.1185/03007995.2013.835255 23952367 Zongo A Guénette L Moisan J Grégoire JP Predictive validity of self-reported measures of adherence to noninsulin antidiabetes medication against control of glycated hemoglobin levels Can J Diabetes 2016 02 40 1 58 65 10.1016/j.jcjd.2015.06.008 26507401 S1499-2671(15)00497-9 Naqvi AA AlShayban DM Ghori SA Mahmoud MA Haseeb A Faidah HS Hassali MA Validation of the general medication adherence scale in Saudi patients with chronic diseases Front Pharmacol 2019 10 633 10.3389/fphar.2019.00633 31231222 PMC6558415 Naqvi AA Hassali MA Jahangir A Nadir MN Kachela B Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses J Drug Assess 2019 8 1 36 42 10.1080/21556660.2019.1579729 30863660 1579729 PMC6407589 Naqvi AA Hassali MA Rizvi M Zehra A Iffat W Haseeb A Jamshed S Development and validation of a novel general medication adherence scale (GMAS) for chronic illness patients in Pakistan Front Pharmacol 2018 10 9 9 1124 10.3389/fphar.2018.01124 30356775 PMC6189444 Mansberger SL Sheppler CR McClure TM Vanalstine CL Swanson IL Stoumbos Z Lambert WE Psychometrics of a new questionnaire to assess glaucoma adherence: the glaucoma treatment compliance assessment tool (an American ophthalmological society thesis) Trans Am Ophthalmol Soc 2013 09 111 1 16 24072942 PMC3783251 Abe RY Wen LD Barker GT Mansberger SL Psychometric Properties of the glaucoma treatment compliance assessment tool (GTCAT) in a Brazilian population J Glaucoma 2018 03 27 3 257 65 10.1097/IJG.0000000000000876 29369851 Barker GT Mansberger SL Psychometric properties of the reduced version of the glaucoma treatment compliance assessment tool (GTCAT) Ophthalmic Epidemiol 2019 02 26 1 55 62 10.1080/09286586.2018.1516785 30204034 Song Y Han H Song H Nam S Nguyen T Kim MT Psychometric evaluation of hill-bone medication adherence subscale Asian Nurs Res (Korean Soc Nurs Sci) 2011 09 5 3 183 8 10.1016/j.anr.2011.09.007 25030368 S1976-1317(11)00008-9 Koschack J Marx G Schnakenberg J Kochen MM Himmel W Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties J Clin Epidemiol 2010 03 63 3 299 306 10.1016/j.jclinepi.2009.06.011 19762213 S0895-4356(09)00206-6 Krousel-Wood M Muntner P Jannu A Desalvo K Re RN Reliability of a medication adherence measure in an outpatient setting Am J Med Sci 2005 09 330 3 128 33 10.1097/00000441-200509000-00006 16174996 S0002-9629(15)32933-5 Nogueira-Silva L Sá-Sousa A Lima MJ Monteiro A Dennison-Himmelfarb C Fonseca JA Translation and cultural adaptation of the hill-bone compliance to high blood pressure therapy scale to Portuguese Rev Port Cardiol 2016 02 35 2 93 7 10.1016/j.repc.2015.07.013 26852304 S0870-2551(16)00008-1 Alsolami FJ Hou X Correa-Velez I An arabic instrument to measure medication adherence in Saudi hypertensive patients ME-JFM 2013 09 11 7 17 23 10.5742/mefm.2014.92409 Nelsen A Trautner BW Petersen NJ Gupta S Rodriguez-Barradas M Giordano TP Naik AD Development and validation of a measure for intention to adhere to HIV treatment AIDS Patient Care STDS 2012 06 26 6 329 34 10.1089/apc.2011.0318 22680281 PMC3412581 Spire B Arnould B Barbier F Durant J Gilquin J Landman R Carret S Saussier C El Kebir S Cohen-Codar I Simplification and first validation of a short battery of patient questionnaires for clinical management of HIV-infected patients: the HIV-SQUAD (symptom quality of life adherence) questionnaire HIV Clin Trials 2009 10 4 215 32 10.1310/hct1004-215 19723610 Y330W76752518K75 Mikhael EM Hussain SA Shawky N Hassali MA Validity and reliability of anti-diabetic medication adherence scale among patients with diabetes in Baghdad, Iraq: a pilot study BMJ Open Diabetes Res Care 2019 7 1 e000658 10.1136/bmjdrc-2019-000658 31354953 bmjdrc-2019-000658 PMC6626478 Jesus-Nunes AP Morais-de-Jesus M Dantas-Duarte A Moreira TM Argolo FC Castro AD Evangelista MA Codes L Bittencourt PL Quarantini LC The Portuguese version of the immunosuppressant therapy adherence scale (ITAS) among liver transplant recipient patients: translation and psychometric properties Ann Hepatol 2018 17 1 104 9 10.5604/01.3001.0010.7541 29311393 01.3001.0010.7541 Wilks S Spivey C Chisholm-Burns M Psychometric re-evaluation of the immunosuppressant therapy adherence scale among solid-organ transplant recipients J Eval Clin Pract 2010 02 16 1 64 8 10.1111/j.1365-2753.2008.01115.x 20367816 JEP1115 Chisholm MA Lance CE Williamson GM Mulloy LL Development and validation of an immunosuppressant therapy adherence barrier instrument Nephrol Dial Transplant 2005 01 20 1 181 8 10.1093/ndt/gfh576 15572384 gfh576 de Geest S Abraham I Gemoets H Evers G Development of the long-term medication behaviour self-efficacy scale: qualitative study for item development J Adv Nurs 1994 02 19 2 233 8 10.1111/j.1365-2648.1994.tb01076.x 8188953 Lee S Bae Y Worley M Law A Validating the modified drug adherence work-up (M-DRAW) tool to identify and address barriers to medication adherence Pharmacy (Basel) 2017 09 8 5 3 - 10.3390/pharmacy5030052 28970464 pharmacy5030052 PMC5622364 Lee S Bae-Shaaw YH Gogineni H Worley MM Law AV Triple strength utility of the modified drug adherence work-up (M-DRAW) tool in a veterans affairs outpatient diabetes clinic Res Social Adm Pharm 2020 07 16 7 914 20 10.1016/j.sapharm.2019.09.063 31629655 S1551-7411(19)30177-9 Sadakathulla I Mateti U Kellarai A Bhat K Adhering to antihypertensive treatment is vitally important Article Salud(i)Ciencia 2019 23 4 314 24 10.21840/siic/157368 Unni EJ Olson JL Farris KB Revision and validation of medication adherence reasons scale (MAR-scale) Curr Med Res Opin 2014 02 30 2 211 21 10.1185/03007995.2013.851075 24102296 Unni E Sternbach N Goren A Using the medication adherence reasons scale (MAR-Scale) to identify the reasons for non-adherence across multiple disease conditions Patient Prefer Adherence 2019 13 993 1004 10.2147/PPA.S205359 31308635 205359 PMC6612984 Fond G Boyer L Boucekine M Aden LA Schürhoff F Tessier A Andrianarisoa M Berna F Brunel L Capdevielle D Chereau I Mallet J Denizot H Dorey JM Dubertret C Dubreucq J Faget C Gabayet F Rey R Richieri R Passerieux C Schandrin A Urbach M Vidailhet P Llorca PM Misdrahi D FACE-SZ (Fonda and Mental Academic Centers of Expertise for Schizophrenia) group Validation study of the medication adherence rating scale. Results from the FACE-SZ national dataset Schizophr Res 2017 04 182 84 9 10.1016/j.schres.2016.10.023 27789187 S0920-9964(16)30467-4 Kao Y Liu Y Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects Compr Psychiatry 2010 51 6 557 65 10.1016/j.comppsych.2010.03.007 20965300 S0010-440X(10)00029-5 Owie GO Olotu SO James BO Reliability and validity of the medication adherence rating scale in a cohort of patients with schizophrenia from Nigeria Trends Psychiatry Psychother 2018 40 2 85 92 10.1590/2237-6089-2017-0077 29768528 S2237-60892018005003103 Sowunmi O Onifade P Psychometric evaluation of medication adherence rating scale (MARS) among Nigerian patients with schizophrenia Niger J Clin Pract 2019 09 22 9 1281 5 10.4103/njcp.njcp_325_18 31489867 NigerJClinPract_2019_22_9_1281_266162 Zemmour K Tinland A Boucekine M Girard V Loubière S Resseguier N Fond G Auquier P Boyer L French Housing First Study Group Validation of the medication adherence rating scale in homeless patients with schizophrenia: results from the French housing first experience Sci Rep 2016 08 18 6 31598 10.1038/srep31598 27534796 srep31598 PMC4989491 Cohen JL Mann DM Wisnivesky JP Home R Leventhal H Musumeci-Szabó TJ Halm EA Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the medication adherence report scale for asthma Ann Allergy Asthma Immunol 2009 10 103 4 325 31 10.1016/s1081-1206(10)60532-7 19852197 Alsous M Alhalaiqa F Abu Farha R Abdel Jalil M McElnay J Horne R Reliability and validity of arabic translation of medication adherence report scale (MARS) and beliefs about medication questionnaire (BMQ)-specific for use in children and their parents PLoS One 2017 12 2 e0171863 10.1371/journal.pone.0171863 28192467 PONE-D-16-41045 PMC5305281 Garcia-Marcos PW Brand PL Kaptein AA Klok T Is the MARS questionnaire a reliable measure of medication adherence in childhood asthma? J Asthma 2016 12 53 10 1085 9 10.1080/02770903.2016.1180699 27177241 Jónsdóttir Halldóra Opjordsmoen S Birkenaes AB Engh JA Ringen PA Vaskinn A Aamo TO Friis S Andreassen OA Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level J Clin Psychopharmacol 2010 04 30 2 169 75 10.1097/JCP.0b013e3181d2191e 20520290 00004714-201004000-00010 Lee L El-Den S Horne R Carter SR Patient satisfaction with information, concerns, beliefs and adherence to topical corticosteroids Patient Educ Couns 2019 06 102 6 1203 9 10.1016/j.pec.2019.01.019 30928342 S0738-3991(18)30398-7 Lin C Ou H Nikoobakht M Broström A Årestedt K Pakpour A Validation of the 5-item medication adherence report scale in older stroke patients in Iran J Cardiovasc Nurs 2018 33 6 536 43 10.1097/JCN.0000000000000488 29649015 Tommelein E Mehuys E van Tongelen I Brusselle G Boussery K Accuracy of the medication adherence report scale (MARS-5) as a quantitative measure of adherence to inhalation medication in patients with COPD Ann Pharmacother 2014 05 48 5 589 95 10.1177/1060028014522982 24523393 1060028014522982 van de Steeg N Sielk M Pentzek M Bakx C Altiner A Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting J Eval Clin Pract 2009 06 15 3 468 72 10.1111/j.1365-2753.2008.01038.x 19366389 JEP1038 Mahler C Hermann K Horne R Ludt S Haefeli WE Szecsenyi J Jank S Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the medication adherence report scale (MARS) in Germany J Eval Clin Pract 2010 06 16 3 574 9 10.1111/j.1365-2753.2009.01169.x 20210821 JEP1169 Sampaio R Azevedo LF Dias CC Horne R Castro Lopes JM Portuguese version of the medication adherence report scale (MARS-9): validation in a population of chronic pain patients J Eval Clin Pract 2019 04 25 2 346 52 10.1111/jep.13098 30648328 Ogedegbe G Mancuso CA Allegrante JP Charlson ME Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients J Clin Epidemiol 2003 06 56 6 520 9 10.1016/s0895-4356(03)00053-2 12873646 S0895435603000532 Saffari M Zeidi IM Fridlund B Chen H Pakpour AH A persian adaptation of medication adherence self-efficacy scale (MASES) in hypertensive patients: psychometric properties and factor structure High Blood Press Cardiovasc Prev 2015 09 22 3 247 55 10.1007/s40292-015-0101-8 25986076 Andy UU Harvie HS Smith AL Propert KJ Bogner HR Arya LA Validation of a self-administered instrument to measure adherence to anticholinergic drugs in women with overactive bladder Neurourol Urodyn 2015 06 34 5 424 8 10.1002/nau.22605 24719232 PMC4420725 Koneru S Shishov M Ware A Farhey Y Mongey A Graham TB Passo MH Houk JL Higgins GC Brunner HI Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting Arthritis Rheum 2007 08 15 57 6 1000 6 10.1002/art.22898 17665465 Kosilov K Loparev S Kuzina I Kosilova L Ivanovskaya M Prokofyeva A Effectiveness of a new tool for self-evaluation of adherence to antimuscarinic drug treatment in older patients of both sexes with urge incontinence Geriatr Gerontol Int 2018 01 18 1 115 22 10.1111/ggi.13150 28921819 Kosilov K Loparev S Kuzina I Shakirova O Zhuravskaya N Lobodenko A Self-assessment of treatment compliance with antimuscarinic drugs and lower urinary tract condition among women with urinary incontinence Int Urogynecol J 2017 11 28 11 1663 9 10.1007/s00192-017-3333-4 28429053 10.1007/s00192-017-3333-4 Kosilov K Loparev S Kuzina I Shakirova O Zhuravskaya N Lobodenko A The effective tool for self-assessment of adherence to treatment in patients with benign prostatic obstruction and overactive bladder symptoms Aging Male 2017 03 20 1 39 44 10.1080/13685538.2016.1247435 28074677 Kosilov KV Loparev SA Kuzina IG Shakirova OV Gainullina YI Kosilova LV Prokofyeva AS A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence Arab J Urol 2017 12 15 4 372 9 10.1016/j.aju.2017.10.007 29234543 S2090-598X(17)30113-4 PMC5717450 Ueno H Yamazaki Y Yonekura Y Park M Ishikawa H Kiuchi T Reliability and validity of a 12-item medication adherence scale for patients with chronic disease in Japan BMC Health Serv Res 2018 07 31 18 1 592 10.1186/s12913-018-3380-7 30064422 10.1186/s12913-018-3380-7 PMC6069892 Battistella M Fleites R Wong R Jassal SV Development, validation, and implementation of a medication adherence survey to seek a better understanding of the hemodialysis patient Clin Nephrol 2016 01 85 1 12 22 10.5414/CN108654 26636327 13946 Athavale AS Bentley JP Banahan BF McCaffrey DJ Pace PF Vorhies DW Development of the medication adherence estimation and differentiation scale (MEDS) Curr Med Res Opin 2019 04 35 4 577 85 10.1080/03007995.2018.1512478 30106315 Cate H Bhattacharya D Clark A Holland R Broadway DC A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial Clin Trials 2015 12 12 6 608 17 10.1177/1740774515592636 26183437 1740774515592636 Cohen HW Shmukler C Ullman R Rivera CM Walker EA Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c) Diabet Med 2010 02 27 2 210 6 10.1111/j.1464-5491.2009.02898.x 20546266 DME2898 PMC4626013 Guénette L Moisan J Préville M Boyer R Measures of adherence based on self-report exhibited poor agreement with those based on pharmacy records J Clin Epidemiol 2005 09 58 9 924 33 10.1016/j.jclinepi.2005.02.002 16085196 S0895-4356(05)00080-6 Morisky DE Green LW Levine DM Concurrent and predictive validity of a self-reported measure of medication adherence Med Care 1986 01 24 1 67 74 10.1097/00005650-198601000-00007 3945130 Shalansky SJ Levy AR Ignaszewski AP Self-reported Morisky score for identifying nonadherence with cardiovascular medications Ann Pharmacother 2004 09 38 9 1363 8 10.1345/aph.1E071 15238622 aph.1E071 Brooks CM Richards JM Kohler CL Soong S Martin B Windsor RA Bailey WC Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales Med Care 1994 03 32 3 298 307 10.1097/00005650-199403000-00008 8145604 Erickson SR Coombs JH Kirking DM Azimi AR Compliance from self-reported versus pharmacy claims data with metered-dose inhalers Ann Pharmacother 2001 09 35 9 997 1003 10.1345/aph.10379 11573875 Kristina SA Putri LR Riani DA Ikawati Z Endarti D Validity of self-reported measure of medication adherence among diabetic patients in Indonesia Int Res J Pharm 2019 08 2 10 7 144 8 10.7897/2230-8407.1007234 Wang Y Lee J Toh M Tang W Ko Y Validity and reliability of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Singapore Diabet Med 2012 09 29 9 e338 44 10.1111/j.1464-5491.2012.03733.x 22672497 Prado JC Kupek E Mion D Validity of four indirect methods to measure adherence in primary care hypertensives J Hum Hypertens 2007 07 21 7 579 84 10.1038/sj.jhh.1002196 17443212 1002196 Jerant A DiMatteo R Arnsten J Moore-Hill M Franks P Self-report adherence measures in chronic illness: retest reliability and predictive validity Med Care 2008 11 46 11 1134 9 10.1097/MLR.0b013e31817924e4 18953223 00005650-200811000-00002 Fahey M Abdulmajeed A Sabra K Measurement of adherence to anti-hypertensive medication as perceived by doctors and patients Qatar Med J 2006 06 2006 1 16 10.5339/qmj.2006.1.16 Ali MA Abou-Taleb DA Mohamed RR Treatment adherence and beliefs about medicines among Egyptian vitiligo patients Dermatol Ther 2016 11 29 6 413 8 10.1111/dth.12397 27594551 Pandey A Raza F Velasco A Brinker S Ayers C Das SR Morisky DE Halm EA Vongpatanasin W Comparison of Morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension J Am Soc Hypertens 2015 06 9 6 420 6.e2 10.1016/j.jash.2015.04.004 26051923 S1933-1711(15)00462-3 Ashur S Shamsuddin K Shah S Bosseri S Morisky DE Reliability and known-group validity of the Arabic version of the 8-item Morisky medication adherence scale among type 2 diabetes mellitus patients East Mediterr Health J 2015 12 13 21 10 722 8 10.26719/2015.21.10.722 26750162 de las Cuevas C Peñate W Psychometric properties of the eight-item Morisky medication adherence scale (MMAS-8) in a psychiatric outpatient setting Int J Clin Health Psychol 2015 15 2 121 9 10.1016/j.ijchp.2014.11.003 30487829 S1697-2600(14)00062-3 PMC6224788 de Oliveira-Filho AD Morisky DE Neves SJF Costa FA de Lyra DP The 8-item Morisky medication adherence scale: validation of a Brazilian-Portuguese version in hypertensive adults Res Social Adm Pharm 2014 10 3 554 61 10.1016/j.sapharm.2013.10.006 24268603 S1551-7411(13)00214-3 DiBonaventura M Wintfeld N Huang J Goren A The association between nonadherence and glycated hemoglobin among type 2 diabetes patients using basal insulin analogs Patient Prefer Adherence 2014 8 873 82 10.2147/PPA.S55550 24971002 ppa-8-873 PMC4069147 Fabbrini G Abbruzzese G Barone P Antonini A Tinazzi M Castegnaro G Rizzoli S Morisky DE Lessi P Ceravolo R REASON study group Adherence to anti-Parkinson drug therapy in the 'REASON' sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the 'Morisky medical adherence scale-8 items' Neurol Sci 2013 11 34 11 2015 22 10.1007/s10072-013-1438-1 23728715 George J Vuong T Bailey MJ Kong DC Marriott JL Stewart K Medication regimen complexity and adherence in patients at risk of medication misadventure J Pharm Pract Res 2015 04 13 36 2 99 102 10.1002/j.2055-2335.2006.tb00580.x Jankowska-Polanska B Uchmanowicz I Chudiak A Dudek K Morisky D Szymanska-Chabowska A Psychometric properties of the Polish version of the eight-item Morisky medication adherence scale in hypertensive adults Patient Prefer Adherence 2016 10 1759 66 10.2147/PPA.S101904 27672314 ppa-10-1759 PMC5026177 Kim J Lee W Hong Y Ryu W Lee KJ Lee W Morisky DE Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea J Epidemiol 2014 24 2 132 40 10.2188/jea.je20130064 24463958 DN/JST.JSTAGE/jea/JE20130064 PMC3983284 Korb-Savoldelli V Gillaizeau F Pouchot J Lenain E Postel-Vinay N Plouin PF Durieux P Sabatier B Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults J Clin Hypertens (Greenwich) 2012 07 14 7 429 34 10.1111/j.1751-7176.2012.00634.x 22747615 Lee W Ahn J Kim J Hong Y Hong SK Kim YT Lee SH Morisky DE Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea J Int Med Res 2013 08 41 4 1098 110 10.1177/0300060513484433 23860015 0300060513484433 Morisky DE Ang A Krousel-Wood M Ward HJ Predictive validity of a medication adherence measure in an outpatient setting J Clin Hypertens (Greenwich) 2008 05 10 5 348 54 10.1111/j.1751-7176.2008.07572.x 18453793 PMC2562622 Nakhaeizadeh M Khalooei A Psychometric properties of Persian version of the 8-item Morisky medication adherence scale in type 2 diabetes patients J Clin Diagn Res 2019 10.7860/jcdr/2019/41408.13076 Sakthong P Chabunthom R Charoenvisuthiwongs R Psychometric properties of the Thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes Ann Pharmacother 2009 05 43 5 950 7 10.1345/aph.1L453 19366872 aph.1L453 Shilbayeh SA Almutairi WA Alyahya SA Alshammari NH Shaheen E Adam A Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic Int J Clin Pharm 2018 02 40 1 56 66 10.1007/s11096-017-0569-5 29189976 10.1007/s11096-017-0569-5 Tan C Teng G Chong K Cheung P Lim A Wee H Santosa A Utility of the Morisky medication adherence scale in gout: a prospective study Patient Prefer Adherence 2016 10 2449 57 10.2147/PPA.S119719 27980395 ppa-10-2449 PMC5144895 Wang Y Kong M Ko Y Psychometric properties of the 8-item Morisky medication adherence scale in patients taking warfarin Thromb Haemost 2012 10 108 4 789 95 10.1160/TH12-05-0368 22836920 12-05-0368 Zongo A Guénette L Moisan J Guillaumie L Lauzier S Grégoire JP Revisiting the internal consistency and factorial validity of the 8-item Morisky medication adherence scale SAGE Open Med 2016 4 2050312116674850 10.1177/2050312116674850 27895914 10.1177_2050312116674850 PMC5117245 Osborn CY Gonzalez JS Measuring insulin adherence among adults with type 2 diabetes J Behav Med 2016 08 9 39 4 633 41 10.1007/s10865-016-9741-y 27062271 10.1007/s10865-016-9741-y PMC4945416 Arnet I Metaxas C Walter PN Morisky DE Hersberger KE The 8-item Morisky medication adherence scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients J Eval Clin Pract 2015 04 21 2 271 7 10.1111/jep.12303 25558796 Shin D Kim C Psychometric evaluation of a Korean version of the 8-item medication adherence scale in rural older adults with hypertension Aust J Rural Health 2013 12 21 6 336 42 10.1111/ajr.12070 24299439 Okello S Nasasira B Muiru AN Muyingo A Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda PLoS One 2016 11 7 e0158499 10.1371/journal.pone.0158499 27367542 PONE-D-16-06877 PMC4930194 Reynolds K Viswanathan HN Muntner P Harrison TN Cheetham TC Hsu JY Gold DT Silverman S Grauer A Morisky DE O'Malley CD Validation of the osteoporosis-specific Morisky medication adherence scale in long-term users of bisphosphonates Qual Life Res 2014 09 23 7 2109 20 10.1007/s11136-014-0662-3 24604077 Reynolds K Viswanathan HN O'Malley CD Muntner P Harrison TN Cheetham TC Hsu JY Gold DT Silverman S Grauer A Morisky DE Psychometric properties of the osteoporosis-specific Morisky medication adherence scale in postmenopausal women with osteoporosis newly treated with bisphosphonates Ann Pharmacother 2012 05 46 5 659 70 10.1345/aph.1Q652 22510666 aph.1Q652 Wickersham KE Sereika SM Kang H Tamres LK Erlen JA Use of a self-report medication adherence scale for measuring adherence to antiretroviral therapy in patients with HIV/AIDS J Nurs Meas 2018 08 26 2 E72 88 10.1891/1061-3749.26.2.E72 30567952 26/2/E72 Athavale AS Bentley JP Banahan BF McCaffrey DJ Pace PF Preliminary development of the medication nonpersistence scale J Am Pharm Assoc (2003) 2017 57 3 389 94.e1 10.1016/j.japh.2017.01.014 28279599 S1544-3191(17)30014-6 Resnick B Wehren L Orwig D Reliability and validity of the self-efficacy and outcome expectations for osteoporosis medication adherence scales Orthop Nurs 2003 22 2 139 47 10.1097/00006416-200303000-00012 12703398 Qi B Resnick B Reliability and validity of the Chinese versions of self-efficacy and outcome expectations for osteoporosis medication adherence scales in Chinese immigrants J Nurs Meas 2014 22 3 472 88 10.1891/1061-3749.22.3.472 25608433 Almeida-Brasil CC Nascimento ED Silveira MR Bonolo PD Ceccato MD New patient-reported outcome measure to assess perceived barriers to antiretroviral therapy adherence: the PEDIA scale Cad Saude Publica 2019 35 5 e00184218 10.1590/0102-311x00184218 31166419 S0102-311X2019000604002 Kalichman SC Cain D Fuhrel A Eaton L di Fonzo K Ertl T Assessing medication adherence self-efficacy among low-literacy patients: development of a pictographic visual analogue scale Health Educ Res 2005 02 20 1 24 35 10.1093/her/cyg106 15253999 cyg106 Zschocke I Mrowietz U Lotzin A Karakasili E Reich K Assessing adherence factors in patients under topical treatment: development of the topical therapy adherence questionnaire (TTAQ) Arch Dermatol Res 2014 04 306 3 287 97 10.1007/s00403-014-1446-x 24509981 PMC3955139 Arnsten J Demas P Farzadegan H Grant R Gourevitch M Chang C Buono D Eckholdt H Howard A Schoenbaum E Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring Clin Infect Dis 2001 10 15 33 8 1417 23 10.1086/323201 11550118 CID001758 PMC2692641 Teixeira A Oliveira C Teixeira M Gaio AR Lobo JM de Almeida IF Almeida V Development and validation of a novel questionnaire for adherence with topical treatments in psoriasis (QATOP) Am J Clin Dermatol 2017 08 18 4 571 81 10.1007/s40257-017-0272-2 28321796 10.1007/s40257-017-0272-2 Walewski KM Cicutto L D'Urzo AD Heslegrave RJ Chapman KR Evaluation of a questionnaire to assess compliance with anti-asthma medications J Asthma 2004 02 41 1 77 83 10.1081/jas-120026064 15046381 Lewin AB LaGreca AM Geffken GR Williams LB Duke DC Storch EA Silverstein JH Validity and reliability of an adolescent and parent rating scale of type 1 diabetes adherence behaviors: the self-care inventory (SCI) J Pediatr Psychol 2009 10 34 9 999 1007 10.1093/jpepsy/jsp032 19423660 jsp032 PMC2782250 Mumtaz T Haider SA Malik JA La Greca AM Translation, validation and effectiveness of self-care inventory in assessing adherence to diabetes treatment J Pak Med Assoc 2016 07 66 7 853 8 27427135 7826 Jansà M Vidal Gimenez Conget Gallindo M Roca Colungo Esmatjes Salamero Psychometric analysis of the Spanish and Catalan versions of the Diabetes Self-Care Inventory-Revised version questionnaire PPA 2013 10 997 10.2147/ppa.s50271 Alhomoud F Alhomoud F Millar I How effectively are your patients taking their medicines? A critical review of the strathclyde compliance risk assessment tool in relation to the 'MMAS' and 'MARS' J Eval Clin Pract 2016 06 22 3 411 20 10.1111/jep.12501 26696012 Lubinga SJ Millar I Babigumira JB Pilot evaluation of the psychometric properties of a self-medication risk assessment tool among elderly patients in a community setting BMC Res Notes 2011 10 11 4 398 10.1186/1756-0500-4-398 21989334 1756-0500-4-398 PMC3199267 Pedrosa RB Rodrigues RC Oliveira HC Alexandre NM Construct validity of the Brazilian version of the self-efficacy for appropriate medication adherence scale J Nurs Meas 2016 24 1 E18 31 10.1891/1061-3749.24.1.E18 27103240 Pedrosa RB Rodrigues RC Adaptation and evaluation of the measurement properties of the Brazilian version of the self-efficacy for appropriate medication adherence scale Rev Lat Am Enfermagem 2016 24 e2692 10.1590/1518-8345.0167.2692 27192417 S0104-11692016000100325 PMC4877142 Risser J Jacobson TA Kripalani S Development and psychometric evaluation of the self-efficacy for appropriate medication use scale (SEAMS) in low-literacy patients with chronic disease J Nurs Meas 2007 15 3 203 19 10.1891/106137407783095757 18232619 Najimi A Mostafavi F Sharifirad G Golshiri P Development and study of self-efficacy scale in medication adherence among Iranian patients with hypertension J Educ Health Promot 2017 6 83 10.4103/jehp.jehp_64_16 29114551 JEHP-6-83 PMC5651667 Blumberg EJ Hovell MF Kelley NJ Vera AY Sipan CL Berg JP Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection J Clin Epidemiol 2005 06 58 6 645 8 10.1016/j.jclinepi.2004.11.022 15878479 S0895-4356(04)00371-3 Muñoz-Moreno JA Fumaz CR Ferrer MJ Tuldrà A Rovira T Viladrich C Bayés R Burger DM Negredo E Clotet B SERAD Validation Team Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (self-reported adherence) study AIDS Res Hum Retroviruses 2007 10 23 10 1166 75 10.1089/aid.2006.0120 17961100 Rofail D Abetz L Viala M Gait C Baladi J Payne K Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument Value Health 2009 12 1 109 17 10.1111/j.1524-4733.2008.00390.x 18637142 S1098-3015(10)60681-X Knobel H Alonso J Casado JL Collazos J González J Ruiz I Kindelan JM Carmona A Juega J Ocampo A GEEMA Study Group Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA study AIDS 2002 03 8 16 4 605 13 10.1097/00002030-200203080-00012 11873004 Ortega Suárez FJ Sánchez Plumed J Pérez Valentín MA Pereira Palomo P Muñoz Cepeda MA Lorenzo Aguiar D Grupo de Estudio Vatren Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus Nefrologia 2011 31 6 690 6 10.3265/Nefrologia.pre2011.Aug.10973 22130285 Rathbun RC Farmer KC Lockhart SM Stephens JR Validity of a stage of change instrument in assessing medication adherence in indigent patients with HIV infection Ann Pharmacother 2007 02 41 2 208 14 10.1345/aph.1H383 17213294 aph.1H383 Willey C Redding C Stafford J Garfield F Geletko S Flanigan T Melbourne K Mitty J Caro JJ Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure Clin Ther 2000 07 22 7 858 71 10.1016/s0149-2918(00)80058-2 10945512 S0149291800800582 Julian FS Martin P Erickson SR Validation of the special projects of national significance adherence tool in HIV/AIDS patients Ann Pharmacother 2010 05 4 44 6 1003 9 10.1345/aph.1m690 Lu M Safren SA Skolnik PR Rogers WH Coady W Hardy H Wilson IB Optimal recall period and response task for self-reported HIV medication adherence AIDS Behav 2008 01 12 1 86 94 10.1007/s10461-007-9261-4 17577653 Gutiérrez-Pereyra F Plaza V Fernández-Rodríguez C Validation of the 'test of the adherence to inhalers' (TAI) for asthma and COPD patients - 2020 - 10.1183/13993003.congress-2015.pa5012 Mancebo MC Pinto A Rasmussen SA Eisen JL Development of the treatment adherence survey-patient version (TAS-P) for OCD J Anxiety Disord 2008 22 1 32 43 10.1016/j.janxdis.2007.01.009 17324553 S0887-6185(07)00024-2 PMC3858011 He W Bonner A Anderson D Patient reported adherence to hypertension treatment: a revalidation study Eur J Cardiovasc Nurs 2016 04 15 2 150 6 10.1177/1474515115603902 26307159 1474515115603902 Giordano TP Guzman D Clark R Charlebois ED Bangsberg DR Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale HIV Clin Trials 2004 5 2 74 9 10.1310/JFXH-G3X2-EYM6-D6UG 15116282 Duncan N Kronenberger W Roberson C Shapiro A VERITAS-PRN: a new measure of adherence to episodic treatment regimens in haemophilia Haemophilia 2010 01 16 1 47 53 10.1111/j.1365-2516.2009.02094.x 19754842 HAE2094 Duncan N Kronenberger W Roberson C Shapiro A VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia Haemophilia 2010 03 16 2 247 55 10.1111/j.1365-2516.2009.02129.x 19925631 HAE2129 Liau YW Cheow C Leung KTY Tan H Low SF Cheen HH Lim WC Tan LL Tan JZ Lee ES Xu S Tan CYK Phang JW Phang JK Lam MH Blalock DV Voils CI Yap KZ Kwan YH A cultural adaptation and validation study of a self-report measure of the extent of and reasons for medication nonadherence among patients with diabetes in Singapore Patient Preference Adherence 2019 07 Volume 13 1241 52 10.2147/ppa.s208736 Blalock DV Zullig LL Bosworth HB Taylor SS Voils CI Self-reported medication nonadherence predicts cholesterol levels over time J Psychosom Res 2019 03 118 49 55 10.1016/j.jpsychores.2019.01.010 30782354 S0022-3999(18)31037-7 Vreeman RC Scanlon ML Tu W Slaven JE McAteer CI Kerr SJ Bunupuradah T Chanthaburanum S Technau K Nyandiko WM Validation of a self-report adherence measurement tool among a multinational cohort of children living with HIV in Kenya, South Africa and Thailand J Int AIDS Soc 2019 05 22 5 e25304 10.1002/jia2.25304 31148372 PMC6543456 Vale FC Santa-Helena ET Santos MA Carvalho WM Menezes PR Basso CR Silva MH Alves AM Nemes MIB Development and validation of the webAd-Q questionnaire to monitor adherence to HIV therapy Rev Saude Publica 2018 52 62 10.11606/s1518-8787.2018052000337 29846437 S0034-89102018000100255 PMC5963908 Phillips T Brittain K Mellins CA Zerbe A Remien RH Abrams EJ Myer L Wilson IB A self-reported adherence measure to screen for elevated HIV viral load in pregnant and postpartum women on antiretroviral therapy AIDS Behav 2017 02 21 2 450 61 10.1007/s10461-016-1448-0 27278548 10.1007/s10461-016-1448-0 PMC5145763 Wilson IB Lee Y Michaud J Fowler FJ Rogers WH Validation of a new three-item self-report measure for medication adherence AIDS Behav 2016 11 20 11 2700 8 10.1007/s10461-016-1406-x 27098408 10.1007/s10461-016-1406-x PMC5071118 Fredericksen R Yang F Gibbons L Edwards T Brown S Fitzsimmons E Alperovitz-Bichell K Godfrey M Wang A Church A Gutierrez C Paez E Dant L Loo S Walcott M Mugavero M Mayer K Mathews W Patrick D Crane P Crane H Development and content validation of measures assessing adherence barriers and behaviors for use in clinical care Res Social Adm Pharm 2019 09 15 9 1168 76 10.1016/j.sapharm.2018.10.001 30327183 S1551-7411(18)30275-4 Linn AJ Vervloet M van Dijk L Smit EG van Weert JC Effects of eHealth interventions on medication adherence: a systematic review of the literature J Med Internet Res 2011 12 5 13 4 e103 10.2196/jmir.1738 22138112 v13i4e103 PMC3278089 Muntner P Joyce C Holt E He J Morisky D Webber LS Krousel-Wood M Defining the minimal detectable change in scores on the eight-item Morisky medication adherence scale Ann Pharmacother 2011 05 45 5 569 75 10.1345/aph.1P677 21521862 aph.1P677 Stoll CR Izadi S Fowler S Green P Suls J Colditz GA The value of a second reviewer for study selection in systematic reviews Res Synth Methods 2019 12 10 4 539 45 10.1002/jrsm.1369 31272125 PMC6989049